ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 5.7 USD -8.8% Market Closed
Updated: May 19, 2024

ESSA Pharma Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ESSA Pharma Inc
Total Liabilities & Equity Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
ESSA Pharma Inc
NASDAQ:EPIX
Total Liabilities & Equity
$144.5m
CAGR 3-Years
24%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Total Liabilities & Equity
$580.9m
CAGR 3-Years
3%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Total Liabilities & Equity
$253.9m
CAGR 3-Years
-11%
CAGR 5-Years
79%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Total Liabilities & Equity
$285.8m
CAGR 3-Years
-3%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Liabilities & Equity
$516.6m
CAGR 3-Years
7%
CAGR 5-Years
26%
CAGR 10-Years
23%
Spectral Medical Inc
TSX:EDT
Total Liabilities & Equity
CA$4.9m
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
-2%

See Also

What is ESSA Pharma Inc's Total Liabilities & Equity?
Total Liabilities & Equity
144.5m USD

Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Total Liabilities & Equity amounts to 144.5m USD.

What is ESSA Pharma Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
61%

Over the last year, the Total Liabilities & Equity growth was -12%. The average annual Total Liabilities & Equity growth rates for ESSA Pharma Inc have been 24% over the past three years , 61% over the past five years .